Precision Immunotherapy Utilizing Adapter CAR-T Cells (AdCAR-T) in Metastatic Breast Cancer Leads to Target Specific Lysis
Open Access
Abstract
A frequent symptom of metastasized breast cancer (BC) includes the development of malignant pleural effusion (MPE), which contains malignant cells derived from the primary tumor site. The poor prognosis of MPE in metastasized BC indicates the necessity for dependable precision oncology and the importance of models representing the heterogenous nature of metastatic BC. In this study, we cultured MPE-derived metastatic tumor cells from four advanced BC patients using organoid technology. We assessed the expression of tumor-associated antigens on MPE-derived organoid lines by flow cytometry (FC). Based on an individual antigen expression pattern, patient-derived organoids were treated with adapter CAR-T cells (AdCAR-T) and biotinylated monoclonal antibodies targeting CD276, HER2, EGFR, TROP2, or EpCAM. Co-culture assays revealed specific organoid lysis by AdCAR-T depending on individual antigen expression patterns. Our results demonstrate that MPE-derived organoids can serve as a reliable tool for assessing the efficacy of AdCAR-T on metastatic BC in a patient-individualized manner. This approach could potentially be applied in a preclinical setting to instruct therapy decisions. Further, our study demonstrates the feasibility of precision immunotherapy utilizing AdCAR-T to target patient-individualized antigen patterns.Keywords
Funding Information
- Deutsche Krebshilfe (DETECT-CTC-HIGH—70114705)
- Open Access Publication Fund of the University of Tübingen (DETECT-CTC-HIGH—70114705)
This publication has 36 references indexed in Scilit:
- T Lymphocytes Expressing a CD16 Signaling Receptor Exert Antibody-Dependent Cancer Cell KillingCancer Research, 2014
- Redirecting Gene-Modified T Cells toward Various Cancer Types Using Tagged AntibodiesClinical Cancer Research, 2012
- Should liver metastases of breast cancer be biopsied to improve treatment choice?Annals of Oncology, 2011
- B7–H3 Ligand Expression by Primary Breast Cancer and Associated With Regional Nodal MetastasisAnnals of Surgery, 2010
- Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010Thorax, 2010
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2Molecular Therapy, 2010
- Modelling breast cancer: one size does not fit allNature Reviews Cancer, 2007
- Antibody-dependent cellular cytotoxicity (ADCC) is mediated by genetically modified antigen-specific human T lymphocytesBlood, 2006
- Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences, 2001
- Pathogenesis of pleural effusion in carcinoma of the breastInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1977